In a recent report, LIGHT (tumour necrosis factor superfamily member 14, TNFSF14), derived from monocytes, was shown to promote osteolysis in NSCLC bone metastases and could be a new therapy target.65 The gene discussed is TNFSF14; the disease is non-small cell lung carcinoma.